Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112953 · ClinicalTrials.gov registry record
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
A clinical trial of AKI, sponsored by University of Chicago.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT04112953: Completed study of AKI, sponsored by University of Chicago.
NCT04112953 is a study of AKI that has completed, run by University of Chicago. The registered enrollment target is 80 participants, above the 72-participant average among 4 other AKI trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04112953, a study of AKI, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand if transesophageal echocardiography during cardiac surgery can predict problems with kidney function after cardiac surgery.
Primary Outcome
Pulsed-wave Doppler measurement of portal vein flow and portal hypertension
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2022-11-15 |
What the finished NCT04112953 record still lists
NCT04112953 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 72-participant average among 4 other AKI trials with a reported enrollment target (11% higher).
The record links to 1 condition, with AKI appearing as the primary indexed condition, and to 0 interventions.
NCT04112953 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04112953 about?
NCT04112953 is a clinical study titled "Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study". The purpose of this study is to better understand if transesophageal echocardiography during cardiac surgery can predict problems with kidney function after cardiac surgery.
What is the current status of trial NCT04112953?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2019-09-04. Estimated completion is 2022-11-15.
What conditions does trial NCT04112953 study?
This clinical trial studies the following conditions: AKI.
Who is sponsoring clinical trial NCT04112953?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04112953 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AKI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
RECRUITING · NA
-
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
COMPLETED · Phase 2
-
Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI